Schrödinger's industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.
Unlock the market timeline & signal feed
New Hiring activity — 1 fresh signal just appeared.
The order this company entered each market — oldest to newest
Applications Scientist, Materials Science, Japan
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
Sign up to see the full signal feed
How Schrödinger's international expansion compares to its competitors
SchrödingerYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 SchrödingerYou | 4 | 0 | -15% | 37 | 29 |
Strategic Deployment Manager, Life Science
View postingGreater Munich Metropolitan Area · last wk.
Strategic Deployment Manager, Life Science
View postingGermany · last wk.
Strategic Deployment Manager
View postingGreater Tokyo Area · 2w ago
De-risk ASD Formulation—Before You Hit the Lab
Ended
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
Ended
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
EndedInsilico Medicine, backed by Qiming Venture Partners, listed on HKEX as 2025's largest biotech IPO, valued at HK$19.51 billion. The AI-driven drug discovery company aims to extend human healthspan.
Zhou Zhifeng of Qiming Ventures ranked 80th on Forbes 2026 Midas List, first Chinese tech/AI investor on list. His portfolio includes Biren, Zhipu, and other AI companies.
Alex Zhou, Managing Partner at Qiming Venture Partners, debuts at No. 80 on Forbes 2026 Midas List, recognized for his AI and technology investments with four portfolio IPOs in 2026.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Schrödinger's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
